Live Price
Live Volume
Chart Volume 0
Volume 0
5 secNeuropace Market Segments
Regular Trading Hours
+0.22(+1.53%)
| Open | $14.36 |
|---|---|
| Close | $14.58 |
| Low | $14.12 |
| Low Change | -0.24 (-1.67%) |
| High | $14.66 |
| High Change | +0.30 (+2.09%) |
| Range | $0.54 |
| Volume | 29.113K |
| Dollar Volume | $424.47K |
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $14.28 |
|---|---|
| Close | $14.28 |
| Low | $14.28 |
| Low Change | 0.00 (0.00%) |
| High | $14.28 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 92.644K |
| Dollar Volume | $1.32M |
Regular Trading Hours Yesterday
+0.11(+0.78%)
| Open | $14.17 |
|---|---|
| Close | $14.28 |
| Low | $14.05 |
| Low Change | -0.12 (-0.85%) |
| High | $14.56 |
| High Change | +0.39 (+2.75%) |
| Range | $0.51 |
| Volume | 126.582K |
| Dollar Volume | $1.81M |
Premarket Yesterday
+0.33(+2.31%)
| Open | $14.30 |
|---|---|
| Close | $14.63 |
| Low | $14.22 |
| Low Change | -0.08 (-0.56%) |
| High | $14.63 |
| High Change | +0.33 (+2.31%) |
| Range | $0.41 |
| Volume | 640 |
| Dollar Volume | $9.36K |
Neuropace News
There is no current news for this stock at the moment.
Neuropace Top Trades
Neuropace's top trade so far today returned +3.26%, while the top short trade returned -1.67%.
Neuropace Moving Averages
| 5 Day Moving Average (SMA5) | $14.27 |
|---|---|
| 10 Day Moving Average (SMA10) | $14.34 |
| 20 Day Moving Average (SMA20) | $14.41 |
| 50 Day Moving Average (SMA50) | $14.68 |
| 100 Day Moving Average (SMA100) | $15.53 |
| 200 Day Moving Average (SMA200) | $15.44 |
Neuropace Statistics
| Average Volume (30 Days) | 146.3K |
|---|---|
| P/E Ratio (Current) | -25.27 |
| EPS (Current) | -$0.56 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$11.61M |
| Cash Ratio | 0.72 |
| Current Ratio | 4.94 |
| Quick Ratio | 3.91 |
| Debt to Equity | 4.97 |
| Enterprise Value | $532.16M |
| EV to EBITDA | -35.91 |
| EV to Sales | 5.38 |
| Price to Book | 40.87 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 4.91 |
| Return on Assets | -0.20% |
| Return on Equity | -1.61% |
Neuropace Stock Splits
There have been no stock splits for Neuropace (NPCE).
Neuropace Dividends
There have been no dividends for Neuropace (NPCE).